One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

Ontario to curb prosecution of HIV non-disclosure cases

6 December 2017 14:46

The Ontario government announced that Crown attorneys will no longer prosecute cases of HIV-positive people who don’t disclose their status to their sexual partner when the person who is HIV-positive has had a suppressed viral load for six months, The Star reports.

The announcement was a response to the federal justice department’s report titled “Criminal Justice System’s Response to Non-Disclosure of HIV,” released last week.

The report, backed by analysis from the Public Health Agency of Canada, concludes that the criminal law should generally not apply to people who are on HIV treatment (which suppresses their viral load and makes transmission unlikely), are not on treatment, but use condoms, or engage only in oral sex.

“The realistic possibility of a transmission test is likely not met in these circumstances,” the report concludes.

The federal report recognized that HIV “is first and foremost a public health issue,” and concluded that non-disclosure prosecutions disproportionately affect people who are Indigenous, gay and Black.


Latest News

DIY faecal transplants carry risks including HIV and hepatitis

Faecal transplants have been used in medical settings to tackle superbugs, but following YouTube videos at home is too risky, say researchers.

16 February 15:30

Gilead's total revenues were $26.1 billion in 2017

For the fourth quarter 2017, Gilead Sciences total revenues were $5.9 billion. For the full year 2017, total revenues were $26.1 billion. HIV and HBV product sales for the full year 2017 were $14.2 billion. Genvoya represents the most successful HIV launch in the U.S. and ...

16 February 09:31

Key vaginal bacteria identified that increase HIV risk in women

Women's risk of HIV significantly associated with key bacteria and their abundance in the vagina.

15 February 16:35

Experimental Drug Kills Flu Virus in a Single Day

Shionogi developed baloxavir marboxil by leveraging discoveries made in anti-HIV drugs, targeting a different kind of enzyme and preventing cells from susceptibility to virus infection in the first place.

15 February 13:27